eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
Malijan‚ Mary Erjoy D. GENEROSO PHARMACEUTICALS AND CHEMICALS‚ INC TIME CONTEXT 1978 and in 1988 - GPC engage in the contract manufacturing of pharmaceutical products for both the domestic and export markets and the Generics Bill came in. SUMMARY / ABSTRACT This case examines the management of Mr. David Genereso in the GENERESO PHARMACEUTICALS AND CHEMICALS‚ INC to become a productive and successful company. Mr. David Generoso was a philosophy graduate of a sectarian university in the
Premium Pharmaceutical drug Strategic management Philippines
Generoso Pharmaceuticals & Chemicals Inc. Case 1 Generoso Pharmaceuticals & Chemicals‚ Inc. Statement of the Problem To determine the possible exercises the Generoso Pharmaceuticals & Chemicals‚ Inc. should take in order to bear in competition and where to find superfluous capital. Areas of Consideration (SWOT ANALYSIS) Strengths * Liquidity of the Company * Ready for expansion * A wide supply for desolate materials * Conservative cash management policies Opportunities
Premium Investment Economics
The Global Pharmaceutical Industry In the pharmaceutical industry market segments can be found depending on the criteria used. For example‚ geographically there are three main market segments (the Triad accounting for 80% and with the strongest growth): The United States of America‚ Europe and Japan with the main future segment being the least developed countries. Another way of classifying the market segments that the pharmaceutical industries face is by those products directed to primary care
Premium Pharmaceutical industry Pharmacology Generic drug
A Case Study Approach for Understanding Supply Chain Orientation in Indian Pharmaceutical Firms TOPIC AREA: OPERATIONS AND SUPPLY CHAIN MANAGEMENT Authors: Dr. J Shanmugan‚ Dr. Sajal Kabiraj Email: jshanmugan@skylineuniversity.com‚ skabiraj@skylineuniversity.com Address: Faculty Block 2‚ Skyline University College‚ P.O Box 1797‚ University City of Sharjah‚ Sharjah‚ UAE Tel: 06 5441155 Ext 234‚ 219 A Case Study Approach for Understanding Supply Chain Orientation in Indian Pharmaceutical Firms
Premium Supply chain management Marketing Supply chain
Bangladesh Pharmaceutical Industry By Sarker Imran‚ RRU‚ BC‚ Canada | | There are several sectors on which Bangladesh can be proud of and undoubtedly the pharmaceutical sector is one of these sectors‚ rather it is the sector‚ which is the second-largest contributor to the government exchequer. There are about 231 companies in this sector and the approximate total market size is about Taka 76‚500 million per year of which about 97% of the total requirement of medicines is created by the
Premium World Trade Organization International trade General Agreement on Tariffs and Trade
Table of Contents Table of Contents i Introduction 1 1 Definition of The Pharmaceutical Industry 1 2 Environmental Analysis 2 2.1 Legal Issues 2 2.2 Political Issues 2 2.3 Economic Issues 2 2.4 Social Issues 2 2.5 Technological Issues 2 3 Forces of Competition 3 4 Value Chain 4 4.1 Discovery 4 4.2 Production Development 4 4.3 Manufacturing 4 4.4 Marketing 4 5 Role of Information Systems & Technology 4 6 GlaxoSmithKline 5 7 United Drug 6 7.1 Company Overview
Premium Pharmaceutical industry Pharmacology Drug discovery
1. Political • Stringent government regulation and powerful purchaser pressures. • Governments focused on pharmaceuticals in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic • European free trade agreements. Social • Ageing populations create pressure on healthcare systems. • Epidemic or chronic diseases (e.g. obesity). Technological • Impact of genetic research on industry. • Utilizing a web of alliances to address multiple customer
Premium Generic drug Pharmaceutical industry Regulation
Objective of the report: The Bangladesh paradox has been one of surprising economic resilience in the face of natural disasters‚ poor governance and political volatility. However‚ a key challenge is whether Bangladesh can move away from an economy that is an impressive underdog‚ to one that can truly join the ranks of the fastest growing economies in the region. Bangladesh has three key attractions for global investors and multinationals: a large base of low-cost labour‚ a large domestic
Premium Investment
1. Overview of the global pharmaceutical industry In 2003‚ Britain’s Guardian newspaper commented that‚ “on the face of it‚ the global pharmaceutical industry looks like the epitome of a modern‚ mature industry that has found a comfortable way to make profits by the billion: it ’s global‚ hi-tech‚ and has the ultimate customer‚ the healthcare budgets of the world ’s richest countries.” Guardian sept 2003 The global pharmaceutical industry is nowadays made up of thousands of companies contained
Premium Generic drug Pharmaceutical industry Pharmacology